References of "KOLH, Philippe"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detail2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H.; Falk, V.; Bax, J. J. et al

in European Heart Journal (2017), 38(36), 2739-2786

[No abstract available]

Detailed reference viewed: 38 (3 ULiège)
Full Text
Peer Reviewed
See detailOne-year and longer dual antiplatelet therapy after an acute coronary syndrome: a Belgian position paper.
Sinnaeve, Peter R.; Desmet, Walter; Descamps, Olivier et al

in Acta Cardiologica (2017), 72(1), 19-27

Acute coronary syndrome patients receive DAPT up to one year after their initial event. Exceptions to the guideline-recommended one-year rule, however, are not uncommon. The reasoning behind shorter ... [more ▼]

Acute coronary syndrome patients receive DAPT up to one year after their initial event. Exceptions to the guideline-recommended one-year rule, however, are not uncommon. The reasoning behind shorter treatments, such as unacceptable bleeding risk or urgent surgery, should be well documented in the patient's charts and discharge letter. Based on recent evidence, patients at high risk for repetitive events should continue on low-dose ticagrelor without a significant interruption at one year and indefinitely in the absence of excess bleeding risk. As there is currently no reimbursement, policy makers and insurers should be made aware of the continuing risk and unmet clinical need in this patient population. Nevertheless, many unsolved questions need to be answered, both through additional analyses from recent trials such as PEGASUS-TIMI 54 or DAPT, as well as new carefully designed clinical studies. [less ▲]

Detailed reference viewed: 30 (1 ULiège)
Full Text
Peer Reviewed
See detailEXCEL and NOBLE: stents or surgery for left main stem stenosis?
Mangiacapra, Fabio; Maeng, Michael; Cayla, Guillaume et al

in EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2017), 13(5), 604-608

Detailed reference viewed: 20 (1 ULiège)
Full Text
Peer Reviewed
See detailMyocardial revascularization in patients with left main or multivessel coronary artery disease at high surgical risk: conventional wisdom versus risk prediction model.
Piccolo, Raffaele; Windecker, Stephan; Kolh, Philippe ULiege

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017), 51(5), 949-951

Detailed reference viewed: 28 (1 ULiège)
Full Text
Peer Reviewed
See detailEditor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS).
Bjorck, M.; Koelemay, M.; Acosta, S. et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2017), 53(4), 460-510

Detailed reference viewed: 20 (1 ULiège)
Full Text
Peer Reviewed
See detailThe quality of a registry based study depends on the quality of the data - without validation, it is questionable.
Venermo, M.; Mani, K.; Kolh, Philippe ULiege

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2017), 53(5), 611-612

Detailed reference viewed: 15 (1 ULiège)
Full Text
Peer Reviewed
See detailManagement of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).
Naylor, A. R.; Ricco, J.-B.; de Borst, G. J. et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2017)

Detailed reference viewed: 11 (1 ULiège)
Full Text
Peer Reviewed
See detail2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Authors/Task Force Members; Aboyans, Victor; Ricco, Jean-Baptiste et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2017)

Detailed reference viewed: 26 (0 ULiège)
Full Text
Peer Reviewed
See detailAdverse events while awaiting myocardial revascularization: a systematic review and meta-analysis.
Head, Stuart J.; da Costa, Bruno R.; Beumer, Berend et al

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017), 52(2), 206-217

OBJECTIVES: The aim of the current study was to estimate adverse event rates while awaiting myocardial revascularization and review criteria for prioritizing patients. METHODS: A PubMed search was ... [more ▼]

OBJECTIVES: The aim of the current study was to estimate adverse event rates while awaiting myocardial revascularization and review criteria for prioritizing patients. METHODS: A PubMed search was performed on 19 January 2015, to identify English-language, original, observational studies reporting adverse events while awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Rates of death, non-fatal myocardial infarction (MI) and emergency revascularization were calculated as occurrence rates per 1000 patient-weeks and pooled using random-effects models. RESULTS: The search yielded 1323 articles, of which 22 were included with 66 410 patients and 607 675 patient-weeks on the wait list. When awaiting CABG, rates per 1000 patient-weeks were 1.1 [95% confidence interval 0.9-1.3] for death, 1.0 [0.6-1.6] for non-fatal MI and 1.8 [0.8-4.1] for emergency revascularization. Subgroup analyses demonstrated consistent outcomes, and sensitivity analyses demonstrated comparable event rates with low heterogeneity. Higher urgency of revascularization was based primarily on angiographic complexity, angina severity, left ventricular dysfunction and symptoms on stress testing, and such patients with a semi-urgent status had a higher risk of death than patients awaiting elective revascularization (risk ratio at least 2.8). Individual studies identified angina severity and left ventricular dysfunction as most important predictors of death when awaiting CABG. Adverse rates per 1000 patient-weeks for patients awaiting PCI were 0.1 [95% confidence interval 0.0-0.4] for death, 0.4 [0.1-1.2] for non-fatal MI and 0.7 [0.4-1.4] for emergency revascularization but were based on only a few old studies. CONCLUSIONS: Rates of death, non-fatal MI and emergency revascularization when awaiting myocardial revascularization are infrequent but higher in specific patients. Countries that not yet have treatment recommendations related to waiting times should consider introducing a maximum to limit adverse events, particularly when awaiting CABG. [less ▲]

Detailed reference viewed: 24 (1 ULiège)
Full Text
Peer Reviewed
See detailInto the Lead: How EJVES Became the Leading Journal in Vascular Surgery.
Bjorck, M.; Kolh, Philippe ULiege

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2017), 54(3), 273-274

Detailed reference viewed: 11 (0 ULiège)
Full Text
Peer Reviewed
See detailPercutaneous coronary interventions with second-generation drug-eluting stent versus off-pump coronary artery bypass grafting: mid-term results.
Berdajs, Denis; Kolh, Philippe ULiege

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017), 52(3), 469-470

Detailed reference viewed: 14 (1 ULiège)
Full Text
Peer Reviewed
See detailGeographical differences in the ratio of percutaneous and surgical myocardial revascularization procedures in the treatment of coronary artery disease.
Piccolo, Raffaele; Windecker, Stephan; Kolh, Philippe ULiege

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017), 52(3), 454-455

Detailed reference viewed: 10 (1 ULiège)
Full Text
Peer Reviewed
See detail2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Jeppsson, Anders; Petricevic, Mate; Kolh, Philippe ULiege et al

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017)

Detailed reference viewed: 13 (1 ULiège)
Full Text
Peer Reviewed
See detail2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
Valgimigli, Marco; Bueno, Hector; Byrne, Robert A. et al

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2017)

Detailed reference viewed: 17 (1 ULiège)